Search

everythinglearnresearchcommunity

for

Search:↓

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

Radiotherapy can cause rare changes in hair color, which should be discussed with patients.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Botulinum toxin type A injections improved hair growth and scalp health in a woman with radiation-induced hair loss.

Presurgical models can effectively and affordably screen cancer prevention agents.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Upadacitinib effectively treats severe alopecia areata and is safe.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Stem cell therapy improves healing and reduces pain in cutaneous radiation syndrome.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

Taking 5-ARI before prostate laser surgery may lead to more blood changes, longer surgery, and more urinary issues.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Alpha-tocopherol does not prevent hair loss from doxorubicin.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Chemotherapy and radiotherapy do not significantly affect obstructive sleep apnea development.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

Combining low-dose dutasteride with finasteride improved a man's hair loss.

Radiation therapy for cancer often causes skin problems like redness, dryness, and pain.